Optimer Biotech Of Taiwan Sets Trials On Breast-Cancer Vaccine
This article was originally published in PharmAsia News
Taiwan's Optimer Biotechnology plans to begin trials by the end of the year to guard against breast cancer
You may also be interested in...
Resolution Medical teamed up with Carbon to introduce more than one million 3D-printed nasal swabs a week to address the shortage for COVID-19 testing.
Early results from the Low-Risk Bicuspid study of the Evolut transcatheter aortic valve replacement system showed low rates of all-cause mortality or stroke.
The reality is that many trials requiring hospital based tests and interventions cannot be replaced, but crisis will spur take up where practical.